Oxygen Biotherapeutics, Inc. (OXBT) Announces The Appointment Of Industry Veteran Gerald Proehl To Its Board Of Directors
4/4/2014 7:10:41 AM
Oxygen Biotherapeutics, Inc., (NASDAQ: OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, announced today that it has appointed Gerald Proehl, former President and CEO of Santarus, Inc. as a member of the company’s Board of Directors. Mr. Proehl’s addition is a new position on the company’s Board.
Help employers find you! Check out all the jobs and post your resume.
comments powered by